Innovative Therapies Days 2024

9–12 Oct 2024 | BESANCON, France

Susanne Behlke

CSO

Med’Inn’Pharma

Besançon, France

13 profile visitsSpeakerGuests

My organisation

MED’INN’Pharma (MIP) is a pre-clinical stage Biotech company founded in 2017 as a spin-off from the French blood bank establishment (EFS) and the French National Institute of Health (INSERM). Our mission is to use our platform technology to develop a pipeline of disease modifying therapies derived from the secretomes of human cells. We are committed to develop drug candidates with durable efficacy by targeting the root cause of diseases. Our platform derived therapeutics can be tailored to several indications and delivery methods. RESOLVIX, the lead candidate issued from our technology plateform, is dedicated to actively resolve, heal and regenerate pathologic inflammation in a wide range of degenerative diseases and conditions and with that intended to positively impacting human health span.
Read more

About me

My organisation

Med’Inn’Pharma

Speaker sessions (2)

Thursday, 10 October 2024

09:20 - 10:25

Session #1 : Upcoming Innovative Therapies

Location:Petit Kursaal roomTrack:Conference

11:15 - 12:15

Session #1 : Upcoming Innovative Therapies

Location:Petit Kursaal roomTrack:Conference